We do not earn a commission from this provider.
OurView Health review
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
OurView advertises $99 a month for semaglutide at any dose. The product page prices month-to-month at $109; the $99 needs three months paid in full at $297.
The $99 requires three months paid in full, billed $297 today. The month-to-month rate on the product page is $109, and the page advertising $99 does not mention the term.
- Advertised $99, actually $109
- Month-to-month price published
- States not published
- FDA warning letters: 0 of 0 matched
- Prices read September 2026
Read first-hand, not from a feed.
Distinct plans priced.
Added by the time you're billed.
This link pays us nothing. It's here because the price is checkable.
The verdict
The dose promise holds up. The simplicity promise is made on a page that does not carry the term the price depends on.
This link pays us nothing. It's here because the price is checkable.
Quick facts
Key facts
- Semaglutide, month to month
- $109
- Semaglutide, three months in full
- $99 a month, $297 today
- Tirzepatide, month to month
- $129
- Tirzepatide, advertised
- $119 a month
- Price by dose?
- No. Any prescribed dose, same price
- Required membership
- None, stated on the weight-loss page
- States served
- Not published on any page we read
Pros and cons
What we like
- The dose-independence claim is stated in the same block as the price and is not contradicted anywhere on the product pages.
- Both plan options appear on the product page with the prepay total spelled out — $297 for three months of semaglutide.
- The pages state plainly that the company is neither a state-licensed pharmacy nor a manufacturer, and that a third party compounds and dispenses.
- The privacy policy gives a street address in Louisiana, which let us run the FDA entity screen.
What could be better
- The headline $99 and $119 are three-month prepay rates advertised on a page that never says so.
- The month-to-month rates are only on the product pages, one click past the page making the pricing claim.
- Only two products are priced, so nothing else in the catalog tests the pricing habits.
- No state list appears on any of the four pages we read.
What it is
A two-product compounded GLP-1 service built entirely around one claim: that the price does not move when the dose does. It is not a pharmacy or a manufacturer, and its product pages say so.
A flat price across doses is a real differentiator, because the usual alternative is a ladder that climbs as you titrate — the same drug, more milligrams, a bigger bill.
Every price we found
| Plan | Advertised | What you actually pay | The gap | Read on |
|---|---|---|---|---|
| Compounded semaglutide, month to monthPer month with no commitment. The $99 requires three months paid in full at $297. | $99 | $109 | September 2026 | |
| Compounded semaglutide, three months in full$297 charged today for three months. | not published | $99 | not comparable | September 2026 |
| Compounded tirzepatide, month to monthPer month with no commitment. The advertised $119 is the prepay rate. | $119 | $129 | September 2026 |
This link pays us nothing. It's here because the price is checkable.
What it actually costs
The weight-loss page says $99 semaglutide and $119 tirzepatide, any prescribed dose. The product pages say month-to-month is $109 and $129, and that $99 and $119 need three months paid in full — $297 up front for semaglutide.
So the two figures a shopper meets first are real prices, just not the ones you pay monthly. That is a prepay rate presented as the standing rate, on a page whose headline is about pricing that stays simple.
What does hold is the dose claim. Nothing on either product page ties price to dose, and nothing hints at a titration surcharge — which several sellers in this batch will not commit to at all.
Who it's wrong for
- Skip it if you are budgeting off the homepage. The number there needs a three-month commitment the homepage does not mention.
- Skip it if you want more than two products. Compounded semaglutide and compounded tirzepatide are the whole catalog.
- Skip it if you want the monthly and prepay rates on the same screen. Nova MD shows four terms per drug with each billed total.
Medications available
- Compounded semaglutideCompounded$109 a month, or $99 on three months paid in full
Any prescribed dose at the same price. Compounded and dispensed by a third-party pharmacy.
- Compounded tirzepatideCompounded$129 a month, advertised at $119
Same dose-independent claim.
Is OurView Health legit?
OurView Health is operated by Our View, 404 E Prien Lake Rd, Lake Charles, LA 70601. We read that off the company’s own privacy policy on September 2026.
What that means
A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.Pharmacy, prescribers and safety checks
- Who prescribesNot named beyond "provider-guided" on the pages we read
- Pharmacy namedNot by name, but the pages state a licensed third party compounds and dispenses
- Price by doseFlat. Any prescribed dose, stated on both product pages
- Membership feeNone required, stated on the weight-loss page
- States servedNot published
Common questions
Is OurView Health $99 a month?
Only on the three-months-paid-in-full option, billed $297 today. The month-to-month rate for compounded semaglutide on the product page is $109, and tirzepatide is $129.
Does the price rise with my dose?
No. Both product pages state the price applies at any prescribed dose, and neither page carries a dose ladder or mentions a titration surcharge anywhere we could find.
Is there a membership fee?
The weight-loss page states no membership is required for either drug, and the product pages price the medication with nothing added beside it.
Why we gave OurView Health a C
Read the full grading rationale
The weight-loss page's whole promise is that the price does not move: 'GLP-1 Pricing That Stays Simple — $99/month Semaglutide, $119/month Tirzepatide, Any prescribed dose.' The product pages price the same two drugs at $109 and $129 month-to-month, with $99 and $119 attached to a three-months-paid-in-full option billed $297 up front. So the two figures a shopper meets first are real, but they are the prepay rates, and the page that makes the simplicity claim is not the page that names the term. The dose promise does hold up — nothing on either product page ties price to dose, which is the part most sellers here quietly do not commit to. The privacy policy names a Lake Charles, Louisiana street address for Our View. FDA warning-letter screen by domain and address: 0 of 0 matched, both controls passing in the same run. No state list on the four pages read.
How we reviewed OurView Health
- We read the weight-loss page, both product pages and the privacy policy first-hand at desktop width, and compared what the marketing page claims against what the checkout page prices.
- Both the advertised rate and the month-to-month rate are quoted verbatim in our capture file, from the pages each one appears on.
- The FDA warning-letter screen was run against the domain and the Lake Charles address in the privacy policy, with a known-positive and a known-negative control passing in the same run.
The 3 pages we read — all on
- Personalized glp 1 page
Compounded Semaglutide Month-to-Month $109 PER MONTH MOST POPULAR 3 Months in Full $99 PER MONTH Save $10— $297 today
- Personalized glp 1 gip page
Compounded Tirzepatide Month-to-Month $129
- Weight loss page
GLP-1 Pricing That Stays Simple $99/month Semaglutide $119/month Tirzepatide Any prescribed dose
This link pays us nothing. It's here because the price is checkable.
Alternatives to OurView Health
| Provider | Grade | Cheapest price |
|---|---|---|
| NativeMed | CCaveat | $149/mo |
| Vytora Health | CCaveat | $149/mo |
| WeightCare | CCaveat | $215/mo |
| Alternate Health Club | CCaveat | $99/mo |
| Cora Health | BMinor gap | $99/mo |